Skip to main content

Peer Review reports

From: An open-label, 1-year extension study of the long-term safety and efficacy of once-daily OROS® hydromorphone in patients with chronic cancer pain

Original Submission
8 Jan 2009 Submitted Original manuscript
9 Jan 2009 Author responded Author comments - John Thipphawong
Resubmission - Version 2
9 Jan 2009 Submitted Manuscript version 2
15 Jan 2009 Author responded Author comments - John Thipphawong
Resubmission - Version 3
15 Jan 2009 Submitted Manuscript version 3
14 Feb 2009 Reviewed Reviewer Report - Stefan Wirz
2 Mar 2009 Reviewed Reviewer Report - robert barkin
18 Jun 2009 Author responded Author comments - John Thipphawong
Resubmission - Version 4
18 Jun 2009 Submitted Manuscript version 4
3 Jul 2009 Reviewed Reviewer Report - robert barkin
4 Jul 2009 Reviewed Reviewer Report - Stefan Wirz
3 Aug 2009 Author responded Author comments - John Thipphawong
Resubmission - Version 5
3 Aug 2009 Submitted Manuscript version 5
21 Aug 2009 Author responded Author comments - John Thipphawong
Resubmission - Version 6
21 Aug 2009 Submitted Manuscript version 6
Publishing
15 Sep 2009 Editorially accepted
15 Sep 2009 Article published 10.1186/1472-684X-8-14

You can find further information about peer review here.

Back to article page